SOMERSET, N.J., Dec. 20, 2007 (PRIME NEWSWIRE) -- Juvent Medical, Inc., an expansion stage medical device innovator with a patented Dynamic Motion Therapy(r) ("DMT") technology for the prevention and treatment of bone loss associated with osteoporosis, the maintenance of postural stability and the enhancement of the circulatory system, announced today that its Medical Director, Victor H. Frankel, M.D., Ph.D., was recently honored by the Musculoskeletal Transplant Foundation ("MTF") at its International Symposium in Vancouver, British Columbia from October 11 to October 13, 2007.
The MTF is a national, non-profit service organization comprised of academic medical institutions, organ procurement organizations and tissue recovery organizations committed to both advancing the science and practice of transplantation, and delivering the highest level of service to tissue donors and their families, as well as recipients and surgeons. The MTF maintains the nation's largest and most complete inventory of bone, ligament, cartilage and skin grafts, and to date has recovered more than 60,000 donors and distributed more than 3 million grafts for transplantation. It has also supported almost $20 million in research to expand the science of transplantation, including grants, fellowships and educational endeavors, and encourages efforts to improve the understanding of donation and transplantation among the medical community and the public at large. The MTF maintains the highest levels of safety assurance and quality control in all phases of its operations. For more information on the MTF, visit their website at www.mtf.org.
Dr. Frankel, an internationally recognized authority on bone disease and surgery, is a co-founder of the MTF, has served on its Board of Directors since its inception in 1987, and was the first Chairman of its Medical Board of Trustees (MBOT). Under his leadership, the MBOT created the donor criteria and recovery protocols and procedures that helped establish the MTF as the premier tissue bank in the United States. Dr. Frankel is also the former chairman and chief executive officer of the New York University (NYU) Medical Center's Hospital for Joint Diseases, and currently serves as a professor of orthopedic surgery at the NYU School of Medicine. In addition, Dr. Frankel has held senior medical positions as chairman, professor of orthopedic surgery, and director of the Biomechanics Laboratory at the University of Washington (Seattle), and is President Emeritus of the Hospital for Joint Diseases. He holds a medical degree from the University of Pennsylvania and a Ph.D. in orthopedic and reconstructive surgery from the University of Upsala, Sweden. In recognition of his achievements and contributions to science, King Carl XVI Gustav of Sweden awarded Dr. Frankel the title of Knight Commander of the Royal Order of the North Star in 1992.
As the Medical Director of Juvent Medical Inc., Dr. Frankel is the Company's primary contact to the medical community, coordinating and directing all continuing research on its DMT technology for the prevention and treatment of osteoporosis. For more information on Juvent Medical, Inc., visit their website at www.juvent.com
The Juvent Medical, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3637